MS
MNTA

Maven Securities’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Maven Securities’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-48,000
Closed -$2.52M – 971
2020
Q3 		$2.52M Buy
+48,000
New +$1.99M 0.21% 107

Maven Securities's MNTA Position: Q4 2020 in Review

Maven Securities sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 48,000 shares — an estimated $2.52M sold.

Maven Securities first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $2.52M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Maven Securities reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Maven Securities sold 48,000 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $2.52M.
  • Maven Securities first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Maven Securities's Momenta Pharmaceuticals, Inc. position peaked at $2.52M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Maven Securities's 13F filing for Q4 2020, filed 12 Feb 2021.